来自MSN4 个月
Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
Insulet Corp.’s PODD groundbreaking Omnipod 5 Automated Insulin Delivery (“AID”) system (Omnipod 5) received the FDA’s approval for use by type 2 diabetes patients (ages 18 years and above).
MD&M East1 年
Omnipod 5 Gets Full Market Release in Germany
Insulet, a tubeless insulin pump technology company, today announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System in Germany, for people aged two-years and older with type ...